<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Anesthesiol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Anesthesiol</journal-id><journal-title-group><journal-title>BMC Anesthesiology</journal-title></journal-title-group><issn pub-type="epub">1471-2253</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5123242</article-id><article-id pub-id-type="publisher-id">285</article-id><article-id pub-id-type="doi">10.1186/s12871-016-0285-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Association between changes in cerebral grey matter volume and postoperative cognitive dysfunction in elderly patients: study protocol for a prospective observational cohort study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0191-9775</contrib-id><name><surname>Goettel</surname><given-names>Nicolai</given-names></name><address><phone>+41 61 556 5228</phone><email>nicolai.goettel@usb.ch</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mistridis</surname><given-names>Panagiota</given-names></name><address><email>panagiota.mistridis@fps-basel.ch</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Berres</surname><given-names>Manfred</given-names></name><address><email>manfred.berres@t-online.de</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Reinhardt</surname><given-names>Julia</given-names></name><address><email>julia.reinhardt@usb.ch</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Stippich</surname><given-names>Christoph</given-names></name><address><email>christoph.stippich@usb.ch</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Monsch</surname><given-names>Andreas U.</given-names></name><address><email>andreas.monsch@fps-basel.ch</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Steiner</surname><given-names>Luzius A.</given-names></name><address><email>luzius.steiner@usb.ch</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Department of Anesthesia, Surgical Intensive Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, University of Basel, Spitalstrasse 21, CH-4031 Basel, Switzerland </aff><aff id="Aff2"><label>2</label>Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland </aff><aff id="Aff3"><label>3</label>Memory Clinic, University Center for Medicine of Aging Basel, Felix Platter Hospital, Basel, Switzerland </aff><aff id="Aff4"><label>4</label>Department of Mathematics and Technology, University of Applied Sciences Koblenz, Koblenz, Germany </aff><aff id="Aff5"><label>5</label>Department of Radiology, Division of Diagnostic and Interventional Neuroradiology, University Hospital Basel, University of Basel, Basel, Switzerland </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>11</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>11</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>16</volume><elocation-id>118</elocation-id><history><date date-type="received"><day>12</day><month>10</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Cognitive decline is frequently observed in elderly patients after major surgery. The pathophysiology of postoperative cognitive dysfunction (POCD) remains unclear. The aim of our investigation is to identify potential associations between brain volume change and POCD in elderly patients undergoing major surgery.</p></sec><sec><title>Methods</title><p>This is a prospective observational cohort study approved by the regional ethics board. We intend to compare specific brain volumes (hippocampus, lateral ventricle, total grey matter volume, regional cortical thickness) on magnetic resonance imaging and cognitive functions determined by a neuropsychological assessment battery in 70 study participants aged &#x02265;65&#x000a0;years before and 3 and 12&#x000a0;months after major noncardiac surgery. Thirty volunteers will be included as matched nonsurgical controls. The primary endpoint of the study is the change in hippocampal volume over time in patients with and without POCD. The secondary endpoint is the correlation between the change in cerebral volume and cognitive function. We will follow the STROBE guidelines for reporting the results of observational studies.</p></sec><sec><title>Discussion</title><p>We hypothesize that surgery under general anesthesia is associated with a loss of cerebral grey matter, and that the degree of postoperative cognitive dysfunction correlates with the extent of atrophy in areas of the brain that are relevant for cognitive functions. The validation of reproducible anatomical biomarkers, such as the specific brain volumes examined in our cohort, may serve to evaluate the effect of preventive strategies and treatment interventions for POCD in follow-up studies.</p></sec><sec><title>Trial registration</title><p>Clinicaltrials.gov <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02045004">NCT02045004</ext-link>. Registered 22 January 2014. Kofam.ch SNCTP000001751. Registered 21 April 2016 (retrospectively registered).</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Postoperative cognitive dysfunction</kwd><kwd>Long-term outcomes</kwd><kwd>Surgery</kwd><kwd>Anesthesia</kwd><kwd>Cerebral volume</kwd></kwd-group><funding-group><award-group><funding-source><institution>Propatient Research Foundation, University Hospital Basel</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p>Anesthesia care for patients in their seventies or eighties has an ever-growing presence in clinical practice given the demographic development in many industrialized countries. Variable degrees of cognitive decline are frequently observed after major surgery in elderly patients and have been defined as postoperative cognitive dysfunction (POCD) [<xref ref-type="bibr" rid="CR1">1</xref>]. Clinical studies have reported an incidence of POCD of up to 41% in surgical patients older than 60&#x000a0;years (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR2">2</xref>]. In many patients, this is a transient problem. But in some patients, cognitive deficits are long-term or permanent [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. POCD may also develop in younger patients [<xref ref-type="bibr" rid="CR3">3</xref>] and after minor surgery [<xref ref-type="bibr" rid="CR4">4</xref>]. The occurrence of POCD is associated with increased mortality and important socioeconomic consequences [<xref ref-type="bibr" rid="CR5">5</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Incidence of POCD after noncardiac surgery</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Study</th><th>Population</th><th>Time for postoperative test</th><th>POCD rate (%)</th></tr></thead><tbody><tr><td>Moller et al. [<xref ref-type="bibr" rid="CR1">1</xref>]</td><td>Patients &#x02265;60 undergoing major abdominal, thoracic, or orthopedic surgery</td><td>1&#x000a0;week and 3&#x000a0;months</td><td>25.8 and 9.9%, respectively</td></tr><tr><td>Monk et al. [<xref ref-type="bibr" rid="CR2">2</xref>]</td><td>Patients &#x0003e;60 undergoing minimally invasive, intraabdominal/thoracic, or orthopedic surgery</td><td>1&#x000a0;week and 3&#x000a0;months</td><td>41.4 and 12.7%, respectively</td></tr><tr><td>Johnson et al. [<xref ref-type="bibr" rid="CR3">3</xref>]</td><td>Patients 40&#x02013;60 undergoing major abdominal or orthopedic surgery</td><td>1&#x000a0;week and 3&#x000a0;months</td><td>19.2 and 6.2%, respectively</td></tr><tr><td>Canet et al. [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td>Patients &#x0003e;60 undergoing minor surgery</td><td>1&#x000a0;week and 3&#x000a0;months</td><td>6.8 and 6.6%, respectively</td></tr></tbody></table><table-wrap-foot><p>
<italic>POCD</italic> postoperative cognitive dysfunction</p></table-wrap-foot></table-wrap>
</p><p>The potential association between exposure to anesthesia and the development of dementia in elderly patients remains a controversial topic [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. So far, a direct association between surgery and long-term cognitive decline has not been established [<xref ref-type="bibr" rid="CR8">8</xref>]. The pathophysiology of POCD is poorly understood, and no preventive strategy or treatment has been described so far [<xref ref-type="bibr" rid="CR9">9</xref>]. A retrospective analysis of cohort data suggests that surgery may be associated with a decrease in brain volume [<xref ref-type="bibr" rid="CR10">10</xref>]; however, no analysis of a potential link between cerebral atrophy and cognitive functions was made. We would like to reproduce and verify these results and investigate a possible relationship with the postoperative cognitive performance in surgical patients.</p><p>The principal objective of this observational cohort study is to prospectively test the hypothesis whether major noncardiac surgery under sevoflurane-based general anesthesia is associated with a loss of cerebral grey matter in elderly patients. We also hypothesize that the degree of POCD correlates with the loss of grey matter in brain areas relevant for cognitive functions.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study design and setting</title><p>This prospective, observational cohort study is being conducted at the University Hospital Basel, Switzerland. Study recruitment commenced in July 2015 and is expected to last for 36&#x000a0;months. The regional ethics committee (EC) approved the study prior to participant inclusion (Ethikkommission Nordwestschweiz, protocol: EKNZ 2014&#x02013;155, 1 August 2014). The study was registered on clinicaltrials.gov (NCT02045004) on 22 January 2014 and on Kofam.ch (SNCTP000001751) on 21 April 2016.</p></sec><sec id="Sec4"><title>Study population</title><p>Two groups of study participants will be investigated in this prospective cohort study. Seventy patients aged &#x02265;65&#x000a0;years undergoing major surgical procedures will be recruited for this study (Group 1). Thirty volunteers aged &#x02265;65&#x000a0;years will be recruited as matched nonsurgical controls (Group 2).</p><sec id="Sec5"><title>Recruitment and informed consent</title><p>Study participants in the surgical group (Group 1) will be recruited as patients of the University Hospital Basel, Switzerland. Eligible patients are identified by screening the daily list of visits in the preoperative anesthesia clinic. They are either contacted personally on the same day, or by mail in a letter including participant information and a consent form. A follow-up phone call by an investigator will provide further information about relevant details of the study. Study participants in the nonsurgical control group (Group 2) will be recruited from an existing study subject registry established by the Memory Clinic at the Felix Platter Hospital, Basel, Switzerland. Nonsurgical controls are matched to surgical patients according to age, gender and level of education.</p><p>The study is conducted with written informed consent from all study subjects and is conducted with respect of the most recent version of the Declaration of Helsinki [<xref ref-type="bibr" rid="CR11">11</xref>]. Participants are informed that participation in the study is voluntary, and that they are free to withdraw at any time. Recruitment and consenting of study participants by members of the research team is in-line with Good Clinical Practice (GCP) [<xref ref-type="bibr" rid="CR12">12</xref>].</p></sec><sec id="Sec6"><title>Inclusion and exclusion criteria</title><p>Study inclusion and exclusion criteria appear in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. All patients aged 65&#x000a0;years or older, American Society of Anesthesiologists&#x02019; physical status I&#x02013;III, who are scheduled from major elective surgery under general anesthesia at the University Hospital Basel, are eligible for study inclusion in Group 1. Further inclusion criteria comprise a home location suitable for testing, German as their first language, and an Instrumental Activities of Daily Living [<xref ref-type="bibr" rid="CR13">13</xref>] score &#x02265;6. Participants in Group 2 are volunteers who present equal inclusion and exclusion criteria, without planned surgery.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Study inclusion and exclusion criteria</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Criterion</th><th>Screening procedure</th></tr></thead><tbody><tr><td colspan="2">Inclusion criteria</td></tr><tr><td>&#x02003;Age &#x02265;65&#x000a0;years</td><td>Medical record</td></tr><tr><td>&#x02003;Home location suitable for testing</td><td>Medical record</td></tr><tr><td>&#x02003;German as a first language</td><td>Medical record or recruitment telephone call</td></tr><tr><td>&#x02003;IADL score &#x02265;6</td><td>Baseline assessment</td></tr><tr><td>&#x02003;ASA physical status I&#x02013;III</td><td>Baseline assessment</td></tr><tr><td>&#x02003;Major elective surgery<sup>a</sup>
</td><td>Medical record</td></tr><tr><td>&#x02003;Planned general anesthesia<sup>a</sup>
</td><td>Baseline assessment</td></tr><tr><td colspan="2">Exclusion criteria</td></tr><tr><td>&#x02003;Cardiac surgery<sup>a</sup>
</td><td>Medical record</td></tr><tr><td>&#x02003;Neurosurgery including carotid endarterectomy, or any type of surgery precluding postoperative testing<sup>a</sup>
</td><td>Medical record</td></tr><tr><td>&#x02003;(Another) major surgery within the study timeline</td><td>Medical record, recruitment telephone call or baseline interview</td></tr><tr><td>&#x02003;General anesthesia up to 3&#x000a0;months prior to inclusion</td><td>Medical record</td></tr><tr><td>&#x02003;Baseline MMSE score &#x0003c;24</td><td>Baseline neuropsychological assessment</td></tr><tr><td>&#x02003;Dementia criteria per DSM-5</td><td>Baseline neuropsychological assessment</td></tr><tr><td>&#x02003;Previous pathological cerebral imaging (if available)</td><td>Medical record</td></tr><tr><td>&#x02003;History of cerebral or cerebrovascular pathology, head trauma, neurodegenerative illness or epilepsy</td><td>Medical record</td></tr><tr><td>&#x02003;Chronic use of psychiatric medication</td><td>Medical record or baseline interview</td></tr><tr><td>&#x02003;Alcohol or substance abuse</td><td>Medical record or baseline interview</td></tr><tr><td>&#x02003;History of chronic pain unrelated to the planned surgery</td><td>Medical record</td></tr><tr><td>&#x02003;Chronic medical illness known to induce encephalopathy</td><td>Medical record</td></tr><tr><td>&#x02003;Any contraindication for MRI (e.g., pacemakers and other MRI-incompatible implantable device)</td><td>Medical record, recruitment telephone call or baseline interview</td></tr><tr><td>&#x02003;Claustrophobia</td><td>Medical record, recruitment telephone call or baseline interview</td></tr><tr><td>&#x02003;Incidentally diagnosed disease or unfavorable course of disease in participants who choose not to be informed</td><td>Any study assessment</td></tr><tr><td>&#x02003;Lack of informed consent</td><td>Recruitment telephone call</td></tr></tbody></table><table-wrap-foot><p>
<italic>ASA</italic> American Society of Anesthesiologists, <italic>DSM-5</italic> Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, <italic>IADL</italic> Instrumental Activities of Daily Living, <italic>MMSE</italic> Mini-Mental State Examination</p><p>
<sup>a</sup>Not applicable for the nonsurgical control group</p></table-wrap-foot></table-wrap>
</p></sec></sec><sec id="Sec7"><title>Outcomes</title><p>The primary endpoint of this study is the degree of change in hippocampal volume over time between patients with and patients without POCD. Other specific cerebral volumes measured are the lateral ventricles, the total grey matter volume, and regional cortical thickness. The secondary endpoint is the correlation between the change in cerebral volume and the change in cognitive function.</p></sec><sec id="Sec8"><title>Study procedures</title><p>Study-related procedures include a baseline multimodal assessment, intraoperative data acquisition and postoperative multimodal assessments on study visits scheduled 1&#x000a0;week, 3&#x000a0;months and 1&#x000a0;year after surgery. Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> shows the flow diagram for the study assessments on a time line.<fig id="Fig1"><label>Fig. 1</label><caption><p>Flow diagram of study procedures</p></caption><graphic xlink:href="12871_2016_285_Fig1_HTML" id="MO1"/></fig>
</p><sec id="Sec9"><title>Anesthetic management</title><p>Anesthesia will be standardized. Intravenous propofol and fentanyl will be used for induction of general anesthesia, atracurium or rocuronium for neuromuscular blockade. Patients will be intubated and mechanically ventilated with an air/oxygen mixture to maintain an end-tidal carbon dioxide at 4.6&#x02009;&#x000b1;&#x02009;0.6 kPa. Inhalational sevoflurane, intravenous fentanyl or remifentanil will be used to maintain anesthesia. Intraoperatively, the dose of anesthetics will be controlled using depth of anesthesia monitoring at a targeted bispectral index (BIS) of 40&#x02013;60 and end-tidal sevoflurane concentration monitoring. Data will be downloaded directly from the patient monitor (IntelliVue&#x02122; MX800, Philips Healthcare, Zurich, Switzerland) and the anesthesia machine (Perseus&#x02122;, Dr&#x000e4;ger, Liebefeld, Switzerland) on a personal computer using ICM+ software (Cambridge Enterprise Ltd, University of Cambridge, United Kingdom).</p></sec><sec id="Sec10"><title>Neuropsychological assessment</title><p>The Consortium to Establish a Registry for Alzheimer&#x02019;s Disease-Neuropsychological Assessment Battery (CERAD-NAB) [<xref ref-type="bibr" rid="CR14">14</xref>], Trail Making Tests A and B [<xref ref-type="bibr" rid="CR15">15</xref>], and phonemic fluency (s-words) [<xref ref-type="bibr" rid="CR16">16</xref>] will be performed preoperatively, at 7&#x000a0;days, 3&#x000a0;months and 1&#x000a0;year postoperatively. Training of all study personnel and supervision of cognitive testing will be carried out by the Memory Clinic at Felix Platter Hospital. Cognitive functions will be quantified using the CERAD-NAB total score [<xref ref-type="bibr" rid="CR17">17</xref>], in its demographically-corrected form [<xref ref-type="bibr" rid="CR18">18</xref>]. A correction for short-term practice effects will be carried out based on previous work [<xref ref-type="bibr" rid="CR19">19</xref>]. Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> shows the neuropsychological subtests used in this study [<xref ref-type="bibr" rid="CR20">20</xref>]. The 15 variables resulting from neuropsychological assessment are converted into standard scores (z-scores) based on a normative sample [<xref ref-type="bibr" rid="CR21">21</xref>], and the z-score changes from baseline are calculated. POCD is diagnosed if the decline is &#x0003e;1.0 standard scores in two or more of the 15 variables based on the diagnostic guideline for mild cognitive impairment and dementia related to Alzheimer&#x02019;s disease by the National Institute on Aging-Alzheimer&#x02019;s Association [<xref ref-type="bibr" rid="CR22">22</xref>] and the American Psychiatric Association&#x02019;s Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [<xref ref-type="bibr" rid="CR23">23</xref>]. Postoperative delirium is assessed using the Delirium Observation Screening scale [<xref ref-type="bibr" rid="CR24">24</xref>] and, if applicable, the Confusion Assessment Method [<xref ref-type="bibr" rid="CR25">25</xref>], administered 3 times daily until the fifth postoperative day.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Subtests of the neuropsychological assessment battery used for diagnosis of POCD</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Test variable</th><th>Test description</th><th>Domain tested</th></tr></thead><tbody><tr><td>CERAD-NAB word list-encoding</td><td>Total number of correctly learned words across three learning trials (number of words per trial&#x02009;=&#x02009;10)</td><td>Verbal episodic learning</td></tr><tr><td>CERAD-NAB word list-delayed free recall</td><td>Total number of correctly remembered words after a delay following encoding</td><td>Verbal episodic memory</td></tr><tr><td>CERAD-NAB word list-savings</td><td>Proportion of correctly recalled words during delayed free recall relative to words learned in learning trial 3</td><td>Verbal episodic memory</td></tr><tr><td>CERAD-NAB word list-discriminability</td><td>Rate of correctly recognized words from encoding</td><td>Verbal episodic memory</td></tr><tr><td>CERAD-NAB word list-intrusion errors</td><td>Total number of intrusions committed during word list-encoding and -delayed free recall</td><td>Executive functions</td></tr><tr><td>CERAD-NAB figures-copy</td><td>Copy of four figures (circle, diamond, overlapping rectangles, cube)</td><td>Visuospatial ability</td></tr><tr><td>CERAD-NAB figures-delayed recall</td><td>Number of correctly reproduced figures from figures-copy following a delay</td><td>Visual memory</td></tr><tr><td>CERAD-NAB figures-savings</td><td>Proportion correctly reproduced figures at figures-delayed recall relative to figures-copy</td><td>Visual memory</td></tr><tr><td>Semantic fluency-animals</td><td>Number of animals produced within 1&#x000a0;min</td><td>Semantic memory</td></tr><tr><td>Boston naming test (15-items)</td><td>Number of spontaneously correctly named black and white line drawings (maximum&#x02009;=&#x02009;15)</td><td>Language</td></tr><tr><td>Trail making test A</td><td>Time required to connect circles numbered from 1 to 25 in ascending order</td><td>Psychomotor speed</td></tr><tr><td>Trail making test B</td><td>Time required to connect circles containing numbers (1&#x02013;13) and letters (A-L) in ascending and alternating order</td><td>Executive functions</td></tr><tr><td>Phonemic fluency</td><td>Number of words starting with the letter S produced within 1&#x000a0;min</td><td>Executive functions</td></tr></tbody></table><table-wrap-foot><p>
<italic>CERAD-NAB</italic> Consortium to Establish a Registry for Alzheimer&#x02019;s Disease-Neuropsychological Assessment Battery. Adapted from Mistridis et al. [<xref ref-type="bibr" rid="CR20">20</xref>]</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec11"><title>Other assessments</title><p>Other assessment tools include the Charlson Comorbidity Index [<xref ref-type="bibr" rid="CR26">26</xref>]; the Instrumental Activities of Daily Living [<xref ref-type="bibr" rid="CR13">13</xref>], the Geriatric Depression Scale [<xref ref-type="bibr" rid="CR27">27</xref>], and the Short Form Health Survey [<xref ref-type="bibr" rid="CR28">28</xref>], and will be assessed at baseline, at 3&#x000a0;months, and 1&#x000a0;year postoperatively. Subjective grading of cognitive functions and subjective grading of pain are determined on numeric rating scales at baseline, 7&#x000a0;days, 3&#x000a0;months and 1&#x000a0;year postoperatively. Subjective grading of change in cognitive functions (five-point Likert scale) and subjective grading of successful surgery (yes/no) are assessed at 7&#x000a0;days, 3&#x000a0;months and 1&#x000a0;year postoperatively.</p></sec><sec id="Sec12"><title>Magnetic resonance imaging</title><p>Cerebral MRI will be performed at baseline, at 3&#x000a0;months, and 1&#x000a0;year postoperatively on the same day as the neuropsychological assessment. MRI analysis will be carried out by the Division of Neuroradiology at the University Hospital Basel. High-resolution anatomic and diffusion cerebral MRI will be performed using the hospital&#x02019;s 3-Tesla MAGNETOM Prisma&#x02122; MRI scanner (Siemens, Zurich, Switzerland). For MRI analysis, we will assume that the same regions as those described in mild cognitive impairment and Alzheimer&#x02019;s disease [<xref ref-type="bibr" rid="CR29">29</xref>] are relevant to POCD. We will perform a region of interest (ROI) analysis (hippocampus, lateral ventricle, total grey matter volume, regional cortical thickness). Cortical reconstruction and volumetric segmentation will be performed with the FreeSurfer software suite [<xref ref-type="bibr" rid="CR30">30</xref>], which is freely available for download online (<ext-link ext-link-type="uri" xlink:href="http://surfer.nmr.mgh.harvard.edu">http://surfer.nmr.mgh.harvard.edu</ext-link>).</p></sec></sec><sec id="Sec13"><title>Statistics</title><sec id="Sec14"><title>Sample size justification</title><p>Sample size is estimated based on data describing hippocampal volume. The clinically relevant difference is defined as the difference in hippocampal volume between normal subjects (2.8&#x02009;&#x000b1;&#x02009;0.5&#x000a0;cm<sup>3</sup>) and patients with mild cognitive impairment (2.4&#x02009;&#x000b1;&#x02009;0.4&#x000a0;cm<sup>3</sup>) [<xref ref-type="bibr" rid="CR29">29</xref>]. Assuming an incidence of POCD of 41% one week after surgery in this age group [<xref ref-type="bibr" rid="CR2">2</xref>], and a standard deviation of the hippocampal volume change of 0.45 in both patients with and without POCD, a total sample size of 56 subjects may detect a difference of 0.4&#x000a0;cm<sup>3</sup> in hippocampal volume [<xref ref-type="bibr" rid="CR29">29</xref>] with a power of 90% at a two-sided significance level of 5%. To compensate for the high loss to follow-up, which is unfortunately typical for studies on POCD [<xref ref-type="bibr" rid="CR31">31</xref>] and estimated at 20%, we will recruit 70 patients in the surgical group (Group 1). The number of study participants in the nonsurgical control group (Group 2) is arbitrarily set at 30.</p></sec><sec id="Sec15"><title>Statistical analysis plan</title><p>The quantitative imaging results will be correlated to the CERAD-NAB total score performance obtained on the same day as the MRI scans. The relationship of changes in volume with intraoperative depth of anesthesia (BIS) and the administered dose of sevoflurane expressed as age-corrected minimum alveolar concentration (MAC) equivalent [<xref ref-type="bibr" rid="CR32">32</xref>] multiplied by time of administration will be calculated. We will use voxel-wise, multivariate analysis of variance (ANOVA) and the classification/prediction procedure on multi-parameter MRI data in order to build optimal composite predictors of patients&#x02019; neuropsychological outcomes. All statistical analyses will be performed using SPSS Statistics software, version 22 (IBM, Inc., Zurich, Switzerland). All graphs will be plotted using Prism, version 6 (GraphPad Software, Inc., La Jolla, CA, USA). An interim analysis will be performed to assess quality of data after primary data acquisition from 20 participants. We will follow the Strengthening the Reporting of Observational studies in Epidemiology (STROBE) statement [<xref ref-type="bibr" rid="CR33">33</xref>] for all future reports related to this study.</p></sec></sec><sec id="Sec16"><title>Data monitoring and stopping rules</title><p>The EC agreed that monitoring would be performed by the interdisciplinary study team. This team will evaluate the progress of the trial, verify the accuracy and completeness of the case report forms, and ensure that all protocol requirements and investigator&#x02019;s obligations are being fulfilled. The progress of the trial is evaluated every 6&#x000a0;months. The investigators may terminate the study prematurely according to certain circumstances (e.g., ethical concerns, insufficient participant recruitment, when the safety of the participants is doubtful or at risk, or when alterations in accepted clinical practice make the continuation of a clinical trial unwise).</p></sec><sec id="Sec17"><title>Study safety and reporting of adverse events</title><p>There are no specific safety concerns related to this study. During initial screening of participants in the recruitment phase, any subject that presents potential safety concerns related to MRI will be excluded from the study. Above all, MRI does not use ionizing radiation, and there are no known harmful side-effects associated with temporary exposure to the strong magnetic field used by MRI scanners [<xref ref-type="bibr" rid="CR34">34</xref>]. However, if a serious adverse event should occur, it will be reported to the EC within the appropriate time frame.</p></sec></sec><sec id="Sec18"><title>Discussion</title><p>This observational cohort study prospectively evaluates the relationship of cerebral grey matter volume and POCD in elderly patients after major noncardiac surgery under sevoflurane anesthesia. The primary hypothesis of this investigation is that POCD is accompanied by a loss of cerebral grey matter. Our secondary hypothesis is that the degree of POCD correlates with the loss of grey matter in brain areas relevant for cognitive functions. There are several potential implications of this study for future clinical practice. The validation of reproducible anatomical parameters or biomarkers, such as the specific brain volumes examined in our cohort, will help to identify high-risk patients and may serve to evaluate the effect of preventive strategies and treatment interventions for POCD in clinical follow-up studies. In summary, findings of this study may contribute to improve the diagnosis and prevention of POCD in the future. In the following, we discuss considerations regarding study design, endpoints, choice of study collective, surgical procedures and anesthetic technique.</p><sec id="Sec19"><title>Study design</title><p>The cohort study design chosen for our study enables investigative research in a real-life clinical context without influencing state-of-the-art medical care of patients. No study-related intervention is planned in participating patients, and risks are minimal. Given the lack of clinical data and missing preventive and/or clinical treatment approaches towards POCD, our study is aimed to investigate an association between the cognitive decline and an anatomical biomarker. At this point, POCD research is limited to noninterventional clinical studies, hence the prospective observational design of this study.</p></sec><sec id="Sec20"><title>Endpoints</title><p>The choice of radiological endpoints of our investigation is based on the findings of AddNeuroMed study [<xref ref-type="bibr" rid="CR29">29</xref>]. Liu et al. reported that the degree of atrophy in specific cortical areas correlates with the results of neuropsychological assessment tests obtained by subjects with various cognitive disorders (unrelated to surgery) [<xref ref-type="bibr" rid="CR29">29</xref>]. We assume that brain areas affected in POCD are comparable to those concerned in Alzheimer&#x02019;s disease or mild cognitive impairment.</p></sec><sec id="Sec21"><title>Methodological considerations</title><sec id="Sec22"><title>Choice of study collective</title><p>Although POCD was described in middle-aged patients [<xref ref-type="bibr" rid="CR3">3</xref>], the disorder has its highest incidence among patients over the age of 65&#x000a0;years. As most research on POCD was done in this age group, we decided to set the cut-off for participant age at 65&#x000a0;years. We excluded subjects with conditions known to induce changes in cerebral anatomy such as Alzheimer&#x02019;s disease and other forms of dementia, a history of severe neurological disease, or chronic pain in order to obtain a patient sample free of pre-existing cognitive disorders that might confound the relationship between brain volumes and POCD. The addition of a group of nonsurgical participants serves to control for practice effects related to neuropsychological assessment, to observe the physiological cerebral atrophy rates in volunteers matched to the surgical group, and to establish a paradigm for further research on POCD.</p></sec><sec id="Sec23"><title>Choice of surgical procedures</title><p>We carefully considered the range of surgical procedures to include in our study. We excluded cardiac surgery because of potential issues with cardiopulmonary bypass, surgery of the brain or extracranial blood vessels, and any type of surgery of the face or neck that would preclude patients&#x02019; active participation in the postoperative neuropsychological assessments. Emergency procedures were also excluded, since we would be unable to measure the patient&#x02019;s baseline. At our institution, abdominal, gynecologic, urologic, vascular and orthopedic procedures are the most commonly performed major noncardiac surgeries in older adults. Most of these surgeries involve a hospital stay of at least 5&#x000a0;days. Although this study is monocentric, we strongly believe that the resulting study cohort is representative of a general surgical population.</p></sec><sec id="Sec24"><title>Choice of anesthetic technique</title><p>In this study with pilot character, we chose to investigate exclusively Sevoflurane-based general anesthesia, in order to standardize anesthetic management as a measure to minimize bias. Sevoflurane anesthesia is delivered by the attending anesthetist primarily based on BIS targets (40&#x02013;60) and clinical judgement. Given that the choice of anesthetic technique only marginally influences the risk of developing POCD in surgical patients [<xref ref-type="bibr" rid="CR35">35</xref>], we intend to examine the effect of other anesthetic drugs (e.g., propofol as total intravenous anesthesia) and other anesthetic techniques (e.g., neuraxial or regional anesthesia) on brain volumes and POCD in follow-up studies with similar research protocols. Airway management is standardized as all patients participating in this study are intubated and mechanically ventilated. Other aspects of intraoperative anesthetic management such as the use of opioids or muscle relaxants and hemodynamic management are left at the discretion of the attending physician following existing institutional guidelines.</p></sec><sec id="Sec25"><title>Diagnosis of POCD</title><p>POCD is a complex neuropsychological disorder presenting as a decline in various cognitive domains after surgery and may at times be difficult to diagnose. Clinical cognitive outcomes research is complicated by the fact that there is no universal definition of POCD. Assessment for POCD comprises a time-intensive combination of neurocognitive function tests, and expert evaluation is mandatory for a valid diagnosis of POCD. In the literature, large differences in methodology (e.g., the test batteries used, the interval between sessions, the endpoints to be analyzed, statistical methods) and diagnostic criteria for POCD are apparent [<xref ref-type="bibr" rid="CR31">31</xref>]. In our study, the diagnosis of POCD is based on a decrease of standard scores in the CERAD-NAB.</p></sec></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ANOVA</term><def><p>Analysis of variance</p></def></def-item><def-item><term>BIS</term><def><p>Bispectral index</p></def></def-item><def-item><term>CERAD-NAB</term><def><p>Consortium to Establish a Registry for Alzheimer&#x02019;s Disease-Neuropsychological Assessment Battery</p></def></def-item><def-item><term>DSM-5</term><def><p>Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition</p></def></def-item><def-item><term>EC</term><def><p>Ethics committee</p></def></def-item><def-item><term>GCP</term><def><p>Good Clinical Practice</p></def></def-item><def-item><term>MAC</term><def><p>Minimum alveolar concentration</p></def></def-item><def-item><term>MMSE</term><def><p>Mini-Mental State Examination</p></def></def-item><def-item><term>MRI</term><def><p>Magnetic resonance imaging</p></def></def-item><def-item><term>POCD</term><def><p>Postoperative cognitive dysfunction</p></def></def-item><def-item><term>ROI</term><def><p>Region of interest</p></def></def-item><def-item><term>STROBE</term><def><p>Strengthening the Reporting of Observational studies in Epidemiology</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>The authors wish to thank Dr. Peter Smielewski for assistance with the setup of ICM+ and Allison Dwileski for proof-reading the manuscript.</p><sec id="FPar1"><title>Funding</title><p>This work was supported by the Propatient Research Foundation, University Hospital Basel, Switzerland. The funding body has no role in the design of the study and collection, analysis and interpretation of data, or in writing the manuscript. This research received no specific grant from any funding agency in the commercial sector.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p>Not applicable.</p></sec><sec id="FPar3"><title>Authors&#x02019; contributions</title><p>NG is the principal investigator, study initiator and research coordinator, study protocol author, obtained ethical approval and drafted this manuscript. LAS is a senior co-investigator, assisted with the original study protocol and revised this manuscript. PM, MB, JR, CS and AUM are co-investigators and revised the original study protocol. All authors read and approved the final manuscript.</p></sec><sec id="FPar4"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar5"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar6"><title>Ethics approval and consent to participate</title><p>Ethics approval for this study (protocol no.: EKNZ 2014-155) was provided by the EC (Ethikkommission Nordwestschweiz) on 1 August 2014. The study is carried out in accordance to the protocol and with principles enunciated in the current version of the Declaration of Helsinki [<xref ref-type="bibr" rid="CR11">11</xref>], the guidelines of GCP [<xref ref-type="bibr" rid="CR12">12</xref>], the Swiss Law and Swiss regulatory authority&#x02019;s requirements. Substantial amendments to the study protocol will only be implemented after approval of the EC.</p><p>The investigators will explain to each participant the nature of the study, its purpose, the procedures involved, the expected duration, the potential risks and benefits and any discomfort it may entail. Each participant will be informed that the participation in the study is voluntary. Participants may withdraw from the study at any time. Withdrawal of consent will not affect subsequent medical assistance and treatment. All participants invited to partake in this study are provided a participant information sheet and a consent form describing the study and providing sufficient information to make an informed decision about participation in the study. The participant is given sufficient time to decide whether or not to participate. The patient information sheet and the consent form has been submitted to the EC, reviewed and approved. The formal written informed consent of each participant is obtained before the participant is submitted to any aspect of the study procedure.</p></sec><sec id="FPar7"><title>Data management and confidentiality</title><p>All data from study participants is stored anonymously. Each subject is assigned a unique identity consisting of a three-digit number. Data entry and coding is performed exclusively by the investigators. Data in paper form or electronic data is stored securely at the University Hospital Basel. Only members of the study team have access to the data; however, direct access to source documents is permitted for purposes of monitoring, audits and inspections by competent authorities.</p></sec><sec id="FPar8"><title>Dissemination</title><p>We plan to present the results of this study at international meetings and to publish it as a manuscript in a peer-reviewed journal. There are no publication restrictions. Authorship eligibility guidelines will be respected. Ultimate authority over any of the publication and dissemination activities belongs to the principal investigator (NG).</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moller</surname><given-names>JT</given-names></name><name><surname>Cluitmans</surname><given-names>P</given-names></name><name><surname>Rasmussen</surname><given-names>LS</given-names></name><name><surname>Houx</surname><given-names>P</given-names></name><name><surname>Rasmussen</surname><given-names>H</given-names></name><name><surname>Canet</surname><given-names>J</given-names></name><etal/></person-group><article-title>Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction</article-title><source>Lancet</source><year>1998</year><volume>351</volume><issue>9106</issue><fpage>857</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(97)07382-0</pub-id><?supplied-pmid 9525362?><pub-id pub-id-type="pmid">9525362</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monk</surname><given-names>TG</given-names></name><name><surname>Weldon</surname><given-names>BC</given-names></name><name><surname>Garvan</surname><given-names>CW</given-names></name><name><surname>Dede</surname><given-names>DE</given-names></name><name><surname>van der Aa</surname><given-names>MT</given-names></name><name><surname>Heilman</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Predictors of cognitive dysfunction after major noncardiac surgery</article-title><source>Anesthesiology</source><year>2008</year><volume>108</volume><issue>1</issue><fpage>18</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1097/01.anes.0000296071.19434.1e</pub-id><?supplied-pmid 18156878?><pub-id pub-id-type="pmid">18156878</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>T</given-names></name><name><surname>Monk</surname><given-names>T</given-names></name><name><surname>Rasmussen</surname><given-names>LS</given-names></name><name><surname>Abildstrom</surname><given-names>H</given-names></name><name><surname>Houx</surname><given-names>P</given-names></name><name><surname>Korttila</surname><given-names>K</given-names></name><etal/></person-group><article-title>Postoperative cognitive dysfunction in middle-aged patients</article-title><source>Anesthesiology</source><year>2002</year><volume>96</volume><issue>6</issue><fpage>1351</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1097/00000542-200206000-00014</pub-id><?supplied-pmid 12170047?><pub-id pub-id-type="pmid">12170047</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canet</surname><given-names>J</given-names></name><name><surname>Raeder</surname><given-names>J</given-names></name><name><surname>Rasmussen</surname><given-names>LS</given-names></name><name><surname>Enlund</surname><given-names>M</given-names></name><name><surname>Kuipers</surname><given-names>HM</given-names></name><name><surname>Hanning</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Cognitive dysfunction after minor surgery in the elderly</article-title><source>Acta Anaesthesiol Scand</source><year>2003</year><volume>47</volume><issue>10</issue><fpage>1204</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1046/j.1399-6576.2003.00238.x</pub-id><?supplied-pmid 14616316?><pub-id pub-id-type="pmid">14616316</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinmetz</surname><given-names>J</given-names></name><name><surname>Christensen</surname><given-names>KB</given-names></name><name><surname>Lund</surname><given-names>T</given-names></name><name><surname>Lohse</surname><given-names>N</given-names></name><name><surname>Rasmussen</surname><given-names>LS</given-names></name></person-group><article-title>Long-term consequences of postoperative cognitive dysfunction</article-title><source>Anesthesiology</source><year>2009</year><volume>110</volume><issue>3</issue><fpage>548</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e318195b569</pub-id><?supplied-pmid 19225398?><pub-id pub-id-type="pmid">19225398</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baranov</surname><given-names>D</given-names></name><name><surname>Bickler</surname><given-names>PE</given-names></name><name><surname>Crosby</surname><given-names>GJ</given-names></name><name><surname>Culley</surname><given-names>DJ</given-names></name><name><surname>Eckenhoff</surname><given-names>MF</given-names></name><name><surname>Eckenhoff</surname><given-names>RG</given-names></name><etal/></person-group><article-title>Consensus statement: First International Workshop on Anesthetics and Alzheimer&#x02019;s disease</article-title><source>Anesth Analg</source><year>2009</year><volume>108</volume><issue>5</issue><fpage>1627</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1213/ane.0b013e318199dc72</pub-id><?supplied-pmid 19372347?><pub-id pub-id-type="pmid">19372347</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seitz</surname><given-names>DP</given-names></name><name><surname>Shah</surname><given-names>PS</given-names></name><name><surname>Herrmann</surname><given-names>N</given-names></name><name><surname>Beyene</surname><given-names>J</given-names></name><name><surname>Siddiqui</surname><given-names>N</given-names></name></person-group><article-title>Exposure to general anesthesia and risk of Alzheimer&#x02019;s disease: a systematic review and meta-analysis</article-title><source>BMC Geriatr</source><year>2011</year><volume>11</volume><fpage>83</fpage><pub-id pub-id-type="doi">10.1186/1471-2318-11-83</pub-id><?supplied-pmid 22168260?><pub-id pub-id-type="pmid">22168260</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avidan</surname><given-names>MS</given-names></name><name><surname>Searleman</surname><given-names>AC</given-names></name><name><surname>Storandt</surname><given-names>M</given-names></name><name><surname>Barnett</surname><given-names>K</given-names></name><name><surname>Vannucci</surname><given-names>A</given-names></name><name><surname>Saager</surname><given-names>L</given-names></name><etal/></person-group><article-title>Long-term cognitive decline in older subjects was not attributable to noncardiac surgery or major illness</article-title><source>Anesthesiology</source><year>2009</year><volume>111</volume><issue>5</issue><fpage>964</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e3181bc9719</pub-id><?supplied-pmid 19786858?><pub-id pub-id-type="pmid">19786858</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhart</surname><given-names>CS</given-names></name><name><surname>Steiner</surname><given-names>LA</given-names></name></person-group><article-title>Can postoperative cognitive dysfunction be avoided?</article-title><source>Hosp Pract (1995)</source><year>2012</year><volume>40</volume><issue>1</issue><fpage>214</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.3810/hp.2012.02.962</pub-id><pub-id pub-id-type="pmid">22406897</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kline</surname><given-names>RP</given-names></name><name><surname>Pirraglia</surname><given-names>E</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>De Santi</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Haile</surname><given-names>M</given-names></name><etal/></person-group><article-title>Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairment</article-title><source>Anesthesiology</source><year>2012</year><volume>116</volume><issue>3</issue><fpage>603</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e318246ec0b</pub-id><?supplied-pmid 22293721?><pub-id pub-id-type="pmid">22293721</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">World Medical Association. Declaration of Helsinki. <ext-link ext-link-type="uri" xlink:href="http://www.wma.net/en/30publications/10policies/b3/index.html">http://www.wma.net/en/30publications/10policies/b3/index.html</ext-link>. Accessed 15 Nov 2016.</mixed-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use</collab></person-group><article-title>ICH harmonized tripartite guideline: Guideline for Good Clinical Practice</article-title><source>J Postgrad Med</source><year>2001</year><volume>47</volume><issue>1</issue><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">11590294</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawton</surname><given-names>MP</given-names></name><name><surname>Brody</surname><given-names>EM</given-names></name></person-group><article-title>Assessment of older people: self-maintaining and instrumental activities of daily living</article-title><source>Gerontologist</source><year>1969</year><volume>9</volume><issue>3</issue><fpage>179</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1093/geront/9.3_Part_1.179</pub-id><?supplied-pmid 5349366?><pub-id pub-id-type="pmid">5349366</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Heyman</surname><given-names>A</given-names></name><name><surname>Mohs</surname><given-names>RC</given-names></name><name><surname>Hughes</surname><given-names>JP</given-names></name><name><surname>van Belle</surname><given-names>G</given-names></name><name><surname>Fillenbaum</surname><given-names>G</given-names></name><etal/></person-group><article-title>The Consortium to Establish a Registry for Alzheimer&#x02019;s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer&#x02019;s disease</article-title><source>Neurology</source><year>1989</year><volume>39</volume><issue>9</issue><fpage>1159</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1212/WNL.39.9.1159</pub-id><?supplied-pmid 2771064?><pub-id pub-id-type="pmid">2771064</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">War Department Adjutant General's Office: Army Individual Test Battery Manual of Directions and Scoring. Washington, DC: US War Department, Adjutant General's Office; 1944.</mixed-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Spreen</surname><given-names>FO</given-names></name><name><surname>Benton</surname><given-names>AL</given-names></name></person-group><source>Manual of instructions for the Neurosensory Center Comprehensive Examination for Aphasia</source><year>1977</year><publisher-loc>Victoria</publisher-loc><publisher-name>University of Victoria</publisher-name></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandler</surname><given-names>MJ</given-names></name><name><surname>Lacritz</surname><given-names>LH</given-names></name><name><surname>Hynan</surname><given-names>LS</given-names></name><name><surname>Barnard</surname><given-names>HD</given-names></name><name><surname>Allen</surname><given-names>G</given-names></name><name><surname>Deschner</surname><given-names>M</given-names></name><etal/></person-group><article-title>A total score for the CERAD neuropsychological battery</article-title><source>Neurology</source><year>2005</year><volume>65</volume><issue>1</issue><fpage>102</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000167607.63000.38</pub-id><?supplied-pmid 16009893?><pub-id pub-id-type="pmid">16009893</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrensperger</surname><given-names>MM</given-names></name><name><surname>Berres</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>KI</given-names></name><name><surname>Monsch</surname><given-names>AU</given-names></name></person-group><article-title>Early detection of Alzheimer&#x02019;s disease with a total score of the German CERAD</article-title><source>J Int Neuropsychol Soc</source><year>2010</year><volume>16</volume><issue>5</issue><fpage>910</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1017/S1355617710000822</pub-id><?supplied-pmid 20682088?><pub-id pub-id-type="pmid">20682088</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhart</surname><given-names>CS</given-names></name><name><surname>Birkner-Binder</surname><given-names>D</given-names></name><name><surname>Gagneux</surname><given-names>A</given-names></name><name><surname>Berres</surname><given-names>M</given-names></name><name><surname>Strebel</surname><given-names>SP</given-names></name><name><surname>Monsch</surname><given-names>AU</given-names></name><etal/></person-group><article-title>Evaluation of a summary score of cognitive performance for use in trials in perioperative and critical care</article-title><source>Dement Geriatr Cogn Disord</source><year>2011</year><volume>31</volume><issue>6</issue><fpage>451</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1159/000329442</pub-id><?supplied-pmid 21778726?><pub-id pub-id-type="pmid">21778726</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mistridis</surname><given-names>P</given-names></name><name><surname>Krumm</surname><given-names>S</given-names></name><name><surname>Monsch</surname><given-names>AU</given-names></name><name><surname>Berres</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>KI</given-names></name></person-group><article-title>The 12 years preceding mild cognitive impairment due to Alzheimer&#x02019;s disease: the temporal emergence of cognitive decline</article-title><source>J Alzheimers Dis</source><year>2015</year><volume>48</volume><issue>4</issue><fpage>1095</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.3233/JAD-150137</pub-id><?supplied-pmid 26402083?><pub-id pub-id-type="pmid">26402083</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berres</surname><given-names>M</given-names></name><name><surname>Monsch</surname><given-names>AU</given-names></name><name><surname>Bernasconi</surname><given-names>F</given-names></name><name><surname>Thalmann</surname><given-names>B</given-names></name><name><surname>Stahelin</surname><given-names>HB</given-names></name></person-group><article-title>Normal ranges of neuropsychological tests for the diagnosis of Alzheimer&#x02019;s disease</article-title><source>Stud Health Technol Inform</source><year>2000</year><volume>77</volume><fpage>195</fpage><lpage>9</lpage><?supplied-pmid 11187541?><pub-id pub-id-type="pmid">11187541</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>MS</given-names></name><name><surname>DeKosky</surname><given-names>ST</given-names></name><name><surname>Dickson</surname><given-names>D</given-names></name><name><surname>Dubois</surname><given-names>B</given-names></name><name><surname>Feldman</surname><given-names>HH</given-names></name><name><surname>Fox</surname><given-names>NC</given-names></name><etal/></person-group><article-title>The diagnosis of mild cognitive impairment due to Alzheimer&#x02019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x02019;s Association workgroups on diagnostic guidelines for Alzheimer&#x02019;s disease</article-title><source>Alzheimers Dement</source><year>2011</year><volume>7</volume><issue>3</issue><fpage>270</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2011.03.008</pub-id><?supplied-pmid 21514249?><pub-id pub-id-type="pmid">21514249</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association; 2013.</mixed-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuurmans</surname><given-names>MJ</given-names></name><name><surname>Shortridge-Baggett</surname><given-names>LM</given-names></name><name><surname>Duursma</surname><given-names>SA</given-names></name></person-group><article-title>The Delirium Observation Screening Scale: a screening instrument for delirium</article-title><source>Res Theory Nurs Pract</source><year>2003</year><volume>17</volume><issue>1</issue><fpage>31</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1891/rtnp.17.1.31.53169</pub-id><?supplied-pmid 12751884?><pub-id pub-id-type="pmid">12751884</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inouye</surname><given-names>SK</given-names></name><name><surname>van Dyck</surname><given-names>CH</given-names></name><name><surname>Alessi</surname><given-names>CA</given-names></name><name><surname>Balkin</surname><given-names>S</given-names></name><name><surname>Siegal</surname><given-names>AP</given-names></name><name><surname>Horwitz</surname><given-names>RI</given-names></name></person-group><article-title>Clarifying confusion: the confusion assessment method. A new method for detection of delirium</article-title><source>Ann Intern Med</source><year>1990</year><volume>113</volume><issue>12</issue><fpage>941</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-113-12-941</pub-id><?supplied-pmid 2240918?><pub-id pub-id-type="pmid">2240918</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charlson</surname><given-names>ME</given-names></name><name><surname>Pompei</surname><given-names>P</given-names></name><name><surname>Ales</surname><given-names>KL</given-names></name><name><surname>MacKenzie</surname><given-names>CR</given-names></name></person-group><article-title>A new method of classifying prognostic comorbidity in longitudinal studies: development and validation</article-title><source>J Chronic Dis</source><year>1987</year><volume>40</volume><issue>5</issue><fpage>373</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/0021-9681(87)90171-8</pub-id><?supplied-pmid 3558716?><pub-id pub-id-type="pmid">3558716</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yesavage</surname><given-names>JA</given-names></name><name><surname>Brink</surname><given-names>TL</given-names></name><name><surname>Rose</surname><given-names>TL</given-names></name><name><surname>Lum</surname><given-names>O</given-names></name><name><surname>Huang</surname><given-names>V</given-names></name><name><surname>Adey</surname><given-names>M</given-names></name><etal/></person-group><article-title>Development and validation of a geriatric depression screening scale: a preliminary report</article-title><source>J Psychiatr Res</source><year>1982</year><volume>17</volume><issue>1</issue><fpage>37</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/0022-3956(82)90033-4</pub-id><?supplied-pmid 7183759?><pub-id pub-id-type="pmid">7183759</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McHorney</surname><given-names>CA</given-names></name></person-group><article-title>Measuring and monitoring general health status in elderly persons: practical and methodological issues in using the SF-36 Health Survey</article-title><source>Gerontologist</source><year>1996</year><volume>36</volume><issue>5</issue><fpage>571</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1093/geront/36.5.571</pub-id><?supplied-pmid 8942101?><pub-id pub-id-type="pmid">8942101</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Paajanen</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Westman</surname><given-names>E</given-names></name><name><surname>Wahlund</surname><given-names>LO</given-names></name><name><surname>Simmons</surname><given-names>A</given-names></name><etal/></person-group><article-title>Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study</article-title><source>Neurobiol Aging</source><year>2011</year><volume>32</volume><issue>7</issue><fpage>1198</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2009.07.008</pub-id><?supplied-pmid 19683363?><pub-id pub-id-type="pmid">19683363</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischl</surname><given-names>B</given-names></name></person-group><article-title>FreeSurfer</article-title><source>Neuroimage</source><year>2012</year><volume>62</volume><issue>2</issue><fpage>774</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.01.021</pub-id><?supplied-pmid 22248573?><pub-id pub-id-type="pmid">22248573</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>LS</given-names></name><name><surname>Larsen</surname><given-names>K</given-names></name><name><surname>Houx</surname><given-names>P</given-names></name><name><surname>Skovgaard</surname><given-names>LT</given-names></name><name><surname>Hanning</surname><given-names>CD</given-names></name><name><surname>Moller</surname><given-names>JT</given-names></name></person-group><article-title>The assessment of postoperative cognitive function</article-title><source>Acta Anaesthesiol Scand</source><year>2001</year><volume>45</volume><issue>3</issue><fpage>275</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1034/j.1399-6576.2001.045003275.x</pub-id><?supplied-pmid 11207462?><pub-id pub-id-type="pmid">11207462</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mapleson</surname><given-names>WW</given-names></name></person-group><article-title>Effect of age on MAC in humans: a meta-analysis</article-title><source>Br J Anaesth</source><year>1996</year><volume>76</volume><issue>2</issue><fpage>179</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1093/bja/76.2.179</pub-id><?supplied-pmid 8777094?><pub-id pub-id-type="pmid">8777094</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Elm</surname><given-names>E</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Pocock</surname><given-names>SJ</given-names></name><name><surname>Gotzsche</surname><given-names>PC</given-names></name><name><surname>Vandenbroucke</surname><given-names>JP</given-names></name><etal/></person-group><article-title>The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title><source>Lancet</source><year>2007</year><volume>370</volume><issue>9596</issue><fpage>1453</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(07)61602-X</pub-id><pub-id pub-id-type="pmid">18064739</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">United States Food and Drug Administration. MRI (Magnetic Resonance Imaging) <ext-link ext-link-type="uri" xlink:href="http://www.fda.gov/Radiation-EmittingProducts/RadiationEmittingProductsandProcedures/MedicalImaging/MRI/default.htm">http://www.fda.gov/Radiation-EmittingProducts/RadiationEmittingProductsandProcedures/MedicalImaging/MRI/default.htm</ext-link>. Accessed 15 Nov 2016.</mixed-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>SE</given-names></name><name><surname>Noel-Storr</surname><given-names>A</given-names></name><name><surname>Ritchie</surname><given-names>CW</given-names></name></person-group><article-title>The impact of general and regional anesthesia on the incidence of post-operative cognitive dysfunction and post-operative delirium: a systematic review with meta-analysis</article-title><source>J Alzheimers Dis</source><year>2010</year><volume>22</volume><issue>Suppl 3</issue><fpage>67</fpage><lpage>79</lpage><?supplied-pmid 20858956?><pub-id pub-id-type="pmid">20858956</pub-id></element-citation></ref></ref-list></back></article>